Kyri van Hoose
Director of Finance/CFO at DERMATA THERAPEUTICS, INC.
Net worth: - $ as of 30/04/2024
Profile
Kyri K.
van Hoose is currently the Vice President-Accounting at Turning Point Therapeutics, Inc. and the Chief Financial Officer & Senior Vice President at Dermata Therapeutics, Inc. Previously, Kyri held the position of Corporate Controller & Senior Director-Finance at ACADIA Pharmaceuticals, Inc. from 2005 to 2016.
In 2019 to 2020, Kyri was the Head-Finance at Curzion Pharmaceuticals, Inc. and from 2020 to 2021, Kyri served as the Chief Financial Officer at TEGA Therapeutics, Inc. Kyri completed an undergraduate degree at the University of Southern California in 2000 and obtained an MBA from the University of California, Irvine in 2005.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 04/01/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Kyri van Hoose active positions
| Companies | Position | Start |
|---|---|---|
| TURG POIN | Comptroller/Controller/Auditor | 05/05/2021 |
| DERMATA THERAPEUTICS, INC. | Director of Finance/CFO | 01/09/2021 |
Former positions of Kyri van Hoose
| Companies | Position | End |
|---|---|---|
TEGA Therapeutics, Inc.
 TEGA Therapeutics, Inc. BiotechnologyHealth Technology TEGA Therapeutics, Inc. produces recombinant heparan sulfate and enzyme replacement therapies for lysosomal storage diseases. The company is based in San Diego, CA. Glass, Jeffrey D. Esko. TEGA Therapeutics was founded by Yitzhak Tor, Timothy Scott, Charles A. Timothy Scott has been the CEO since incorporation. | Director of Finance/CFO | 30/04/2021 |
Curzion Pharmaceuticals, Inc.
 Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/04/2020 |
| ACADIA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 01/02/2016 |
Training of Kyri van Hoose
| University of Southern California | Undergraduate Degree |
| University of California, Irvine | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| DERMATA THERAPEUTICS, INC. | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| Private companies | 3 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
TEGA Therapeutics, Inc.
TEGA Therapeutics, Inc. BiotechnologyHealth Technology TEGA Therapeutics, Inc. produces recombinant heparan sulfate and enzyme replacement therapies for lysosomal storage diseases. The company is based in San Diego, CA. Glass, Jeffrey D. Esko. TEGA Therapeutics was founded by Yitzhak Tor, Timothy Scott, Charles A. Timothy Scott has been the CEO since incorporation. | Health Technology |
Curzion Pharmaceuticals, Inc.
Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Kyri van Hoose